Two siblings with a homozygous MTHFR C677T (G80A-RFC1) mutation and stroke

Massimo Barbagallo1, Piero Pavone, Gemma Incorpora

  • 1Department of Pediatrics, University of Catania, Catania, Italy.

Insights

Childhood stroke can be linked to MTHFR gene mutations. This study identifies a family with multiple arterial ischemic stroke (AIS) patients who have homozygous MTHFR C677T mutations but lack hyperhomocysteinemia.

Area of Science:

  • Genetics
  • Neurology
  • Pediatrics

Background:

  • Childhood stroke (arterial ischemic stroke - AIS) is uncommon.
  • Methylenetetrahydrofolate reductase (MTHFR) gene C677T mutations are potential risk factors, often associated with hyperhomocysteinemia.

Observation:

  • A family with two brothers diagnosed with AIS was studied.
  • One sibling presented at age 4 with neurological deficits; his older brother had died at age 7 from AIS.
  • Genetic analysis revealed homozygous MTHFR gene C677T (G80A-RFC1) mutations in affected siblings and a healthy older brother, with heterozygous mutations in parents.

Findings:

  • This is the first reported family with multiple AIS patients carrying homozygous MTHFR gene C677T (G80A-RFC1) mutations.
  • Crucially, none of the affected family members exhibited hyperhomocysteinemia, a condition typically linked to MTHFR mutations and vascular damage.

Implications:

  • The findings challenge the established role of hyperhomocysteinemia as the sole mediator of vascular damage in MTHFR C677T-associated stroke.
  • Further research is needed to elucidate alternative pathogenic mechanisms for stroke in individuals with these specific MTHFR mutations.
Abstract

Related Concept Videos

Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Genetic Lingo01:11

Genetic Lingo

Overview
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.